BusinessFDA & Industry Veteran Brian E. Harvey, MD, PhD, Joins Thetis Pharmaceuticals as Senior Medical DirectorBy Nasdaq OMXMay 7, 2018, 4:27 PM UTC
BusinessCURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery ProductionBy Nasdaq OMXMay 1, 2018, 12:57 PM UTC
BusinessCrownBio Launches New Humanized Target Model for ImmunotherapyBy Nasdaq OMXApr 26, 2018, 12:00 PM UTC
BusinessBiopharmaceutical Veteran Joins CURE Pharmaceutical to Lead ManufacturingBy Nasdaq OMXMar 14, 2018, 1:01 PM UTC
BusinessInside Science: Alzheimer's Drug Trials Keep Failing -- It May Be Because We Don't Understand the DiseaseBy Nasdaq OMXMar 13, 2018, 8:29 PM UTC
BusinessCrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology AgentsBy Nasdaq OMXMar 13, 2018, 12:00 PM UTC
BusinessFirst Comprehensive Clinical Site Initiation Benchmark, Developed by Tufts Center for the Study of Drug Development, Finds Study Startup Is Lengthy and InefficientBy Nasdaq OMXMar 7, 2018, 2:01 PM UTC
BusinessWebinar to Reveal Data Supporting the Use of MuScreen™ for Preclinical Immunotherapeutic DevelopmentBy Nasdaq OMXFeb 27, 2018, 1:01 PM UTC
